Sfoglia per Autore
380 POSTER Association of miR21, miR31, miR143, miR145 and let-7a-1 levels with histopathologic features of colorectal cancer
2007 O. Slaby; M. Svoboda; P. Fabian; I. Garajova ; [..]; R. Vyzula
[Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study]
2008 Garajová, I; Slabý, O; Svoboda, M; Fabian, P; Silák, J; Smerdová, T; Kocák, I; Růzicková, J; Hoch, J; Vyzula, R
Altered expression of heat shock protein 110 (HSP110), hypoxia up- regulated 1 (HYOU1) and translationally controled tumor protein (TCTP) during colorectal cancer progression
2008 O. Slaby; K. Sobkova; M. Svoboda; I. Garajova; [..] ; R. Vyzula
[Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma]
2008 Garajová, I; Svoboda, M; Slabý, O; Kocáková, I; Fabian, P; Kocák, I; Vyzula, R
Antiapoptotic genes are overexpressed in the group of patients with locally advanced rectal adenocarcinomas who do not respond to neoadjuvant chemoradiotherapy
2008 I. Garajova; O. Slaby; M. Svoboda; P. Fabian; J. Silak; I. Kocakova; I. Kocak; J. Ruzickova; J. Hoch; R. Vyzula
Prognostic significance of tumor-infiltrating cytotoxic T-cells in colorectal cancer
2008 P. Fabian; I. Garajova; M. Svoboda; [..]; R. Nenutil
Significant overexpression of Hsp110 gene during colorectal cancer progression
2009 Slaby, O; Sobkova, K; Svoboda, M; Garajova, I; Fabian, P; Hrstka, R; Nenutil, R; Sachlova, M; Kocakova, I; Michalek, J; Smerdova, T; Knoflickova, D; Vyzula, R
Second-line chemotherapy in patients with biliary tract cancer.
2011 G. Brandi; S. Di Girolamo; F. de Rosa; J. Corbelli; V. Agostini; I. Garajova; C. Longobardi; M. Paragona; G. Ercolani; A. D. Pinna; G. Biasco
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients.
2011 Longobardi C; Brandi G; Bruera G; Corbelli J; de Rosa F; Di Girolamo S; Casolino R; Agostini V; Garajovà I; Biasco G; Ficorella C.
Second-line chemotherapy in biliary tract cancer patients.
2011 Corbelli J; Di Girolamo S; de Rosa F; Agostini V; Garajovà I; Longobardi C; Paragona M; Ercolani G; Pinna AD; Biasco G; Brandi G.
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA
2011 G. Brandi ; S. Di Girolamo ; A. Farioli ; F. de Rosa ; S. Curti ; J. Corbelli ; C. Longobardi ; V. Agostini ; I. Garajovà; M. Paragona ; F. S. Violante ; G. Biasco ; S. Mattioli
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma
2011 Mattioli S; Di Girolamo S; Farioli A; de Rosa F; Curti S; Corbelli J; Longobardi C; Agostini V; Garajovà I; Paragona M; Violante FS; Biasco G; Brandi G
The follow-up issues: from the necessity to the opportunity
2011 Brandi G; Nannini M; Longobardi C; Maleddu A; Saponara M; Di Tullio P; Degli Esposti C; Katzinas J; Di Girolamo S; de Rosa F; Agostini V; Macchini M; Rubino D; Pini S; Pallotti M; Paragona M; Lolli C; Corbelli J; Garajovà I; Vecchiarelli S; Mandrioli A; Zucchini G; Pantaleo MA; Di Marco M; Cucchetti A; Biasco G.
Neoadjuvant treatment in rectal cancer: actual status.
2011 I. Garajovà; S. Di Girolamo; F. de Rosa; J. Corbelli; V. Agostini; G. Biasco; G. Brandi
Occupational exposure to asbestos: a putative unknown risk factor for intrahepatic cholangiocarcinoma.
2011 Brandi G; Di Girolamo S; Farioli A; de Rosa F; Curti S; Corbelli J; Longobardi C; Agostini V; Garajová I; Paragona M; Violante FS; Biasco G; Mattioli S.
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.
2012 Brandi G;Corbelli J;de Rosa F;Di Girolamo S;Longobardi C;Agostini V;Garajová I;La Rovere S;Ercolani G;Grazi GL;Pinna AD;Biasco G
Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation.
2013 Garajová I; Nepoti G; Paragona M; Brandi G; Biasco G
Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer
2014 Garajová, Ingrid; Le Large, Tessa Y.; Frampton, Adam E.; Rolfo, Christian; Voortman, Johannes; Giovannetti, Elisa
Follow-up del cancro del pancreas esocrino
2015 Agostini Valentina, Barbera Maria Aurelia, Brighi Nicole, Casolino Raffaella, Corbelli Jody, Dall'Olio Filippo Gustavo, De Lorenzo Stefania, De Rosa Francesco, Degli Esposti Claudio, Di Girolamo Stefania, Di Marco Mariacristina, Di Tullio Piergiorgio, Frega Giorgio, Freier Eva, Garajova Ingrid, Gatto Lidia, Grassi Elisa, Katsinas Giovanna, Lolli Cristian, Macchini Marina, Maleddu Alessandra, Mandrioli Anna, Minchillo Santino, Nannini Margherita, Palloni Andrea, Pallotti Maria Caterina, Pantaleo Maria Abbondanza, Paragona Marco, Pini Sara, Saponara Maristella, Vecchiarelli Silvia, Venturi Michela, Verlicchi Lea, Zucchini Giorgia
MicroRNA profiling of primary pulmonary enteric adenocarcinoma shows similarity with lung cancer and pancreatic cancer
2015 Ingrid Garajová; Niccola Funel; Michelangelo Fiorentino; [..]; Elisa Giovannetti
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
380 POSTER Association of miR21, miR31, miR143, miR145 and let-7a-1 levels with histopathologic features of colorectal cancer | O. Slaby; M. Svoboda; P. Fabian; I. Garajova ; [..]; R. Vyzula | 2007-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
[Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study] | Garajová, I; Slabý, O; Svoboda, M; Fabian, P; Silák, J; Smerdová, T; Kocák, I; Růzicková, J; Hoch..., J; Vyzula, R | 2008-01-01 | CASOPIS LEKARU CESKYCH | - | 1.01 Articolo in rivista | - |
Altered expression of heat shock protein 110 (HSP110), hypoxia up- regulated 1 (HYOU1) and translationally controled tumor protein (TCTP) during colorectal cancer progression | O. Slaby; K. Sobkova; M. Svoboda; I. Garajova; [..] ; R. Vyzula | 2008-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
[Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma] | Garajová, I; Svoboda, M; Slabý, O; Kocáková, I; Fabian, P; Kocák, I; Vyzula, R | 2008-01-01 | KLINICKÁ ONKOLOGIE | - | 1.01 Articolo in rivista | - |
Antiapoptotic genes are overexpressed in the group of patients with locally advanced rectal adenocarcinomas who do not respond to neoadjuvant chemoradiotherapy | I. Garajova; O. Slaby; M. Svoboda; P. Fabian; J. Silak; I. Kocakova; I. Kocak; J. Ruzickova; J. ...Hoch; R. Vyzula | 2008-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Prognostic significance of tumor-infiltrating cytotoxic T-cells in colorectal cancer | P. Fabian; I. Garajova; M. Svoboda; [..]; R. Nenutil | 2008-01-01 | - | - | 4.03 Poster | - |
Significant overexpression of Hsp110 gene during colorectal cancer progression | Slaby, O; Sobkova, K; Svoboda, M; Garajova, I; Fabian, P; Hrstka, R; Nenutil, R; Sachlova, M; Koc...akova, I; Michalek, J; Smerdova, T; Knoflickova, D; Vyzula, R | 2009-01-01 | ONCOLOGY REPORTS | - | 1.01 Articolo in rivista | - |
Second-line chemotherapy in patients with biliary tract cancer. | G. Brandi; S. Di Girolamo; F. de Rosa; J. Corbelli; V. Agostini; I. Garajova; C. Longobardi; M. P...aragona; G. Ercolani; A. D. Pinna; G. Biasco | 2011-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients. | Longobardi C; Brandi G; Bruera G; Corbelli J; de Rosa F; Di Girolamo S; Casolino R; Agostini V; G...arajovà I; Biasco G; Ficorella C. | 2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.03 Poster | - |
Second-line chemotherapy in biliary tract cancer patients. | Corbelli J; Di Girolamo S; de Rosa F; Agostini V; Garajovà I; Longobardi C; Paragona M; Ercolani ...G; Pinna AD; Biasco G; Brandi G. | 2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.03 Poster | - |
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA |
G. Brandi ; S. Di Girolamo ; A. Farioli ; F. de Rosa ; S. Curti ; J. Corbelli ; C. Longobardi ; V.... Agostini ; I. Garajovà; M. Paragona ; F. S. Violante ; G. Biasco ; S. Mattioli |
2011-01-01 | - | - | 4.03 Poster | - |
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma | Mattioli S; Di Girolamo S; Farioli A; de Rosa F; Curti S; Corbelli J; Longobardi C; Agostini V; G...arajovà I; Paragona M; Violante FS; Biasco G; Brandi G | 2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.03 Poster | - |
The follow-up issues: from the necessity to the opportunity | Brandi G; Nannini M; Longobardi C; Maleddu A; Saponara M; Di Tullio P; Degli Esposti C; Katzinas ...J; Di Girolamo S; de Rosa F; Agostini V; Macchini M; Rubino D; Pini S; Pallotti M; Paragona M; Lolli C; Corbelli J; Garajovà I; Vecchiarelli S; Mandrioli A; Zucchini G; Pantaleo MA; Di Marco M; Cucchetti A; Biasco G. | 2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.03 Poster | - |
Neoadjuvant treatment in rectal cancer: actual status. | I. Garajovà; S. Di Girolamo; F. de Rosa; J. Corbelli; V. Agostini; G. Biasco; G. Brandi | 2011-01-01 | CHEMOTHERAPY RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |
Occupational exposure to asbestos: a putative unknown risk factor for intrahepatic cholangiocarcinoma. | Brandi G; Di Girolamo S; Farioli A; de Rosa F; Curti S; Corbelli J; Longobardi C; Agostini V; Gar...ajová I; Paragona M; Violante FS; Biasco G; Mattioli S. | 2011-01-01 | - | s.n | 4.03 Poster | - |
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. | Brandi G;Corbelli J;de Rosa F;Di Girolamo S;Longobardi C;Agostini V;Garajová I;La Rovere S;Ercola...ni G;Grazi GL;Pinna AD;Biasco G | 2012-01-01 | LANGENBECK'S ARCHIVES OF SURGERY | - | 1.01 Articolo in rivista | - |
Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation. | Garajová I; Nepoti G; Paragona M; Brandi G; Biasco G | 2013-01-01 | EUROPEAN JOURNAL OF CANCER CARE | - | 1.01 Articolo in rivista | - |
Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer | Garajová, Ingrid; Le Large, Tessa Y.; Frampton, Adam E.; Rolfo, Christian; Voortman, Johannes; Gi...ovannetti, Elisa | 2014-01-01 | BIOMED RESEARCH INTERNATIONAL | - | 1.01 Articolo in rivista | - |
Follow-up del cancro del pancreas esocrino | Agostini Valentina, Barbera Maria Aurelia, Brighi Nicole, Casolino Raffaella, Corbelli Jody, Dall...'Olio Filippo Gustavo, De Lorenzo Stefania, De Rosa Francesco, Degli Esposti Claudio, Di Girolamo Stefania, Di Marco Mariacristina, Di Tullio Piergiorgio, Frega Giorgio, Freier Eva, Garajova Ingrid, Gatto Lidia, Grassi Elisa, Katsinas Giovanna, Lolli Cristian, Macchini Marina, Maleddu Alessandra, Mandrioli Anna, Minchillo Santino, Nannini Margherita, Palloni Andrea, Pallotti Maria Caterina, Pantaleo Maria Abbondanza, Paragona Marco, Pini Sara, Saponara Maristella, Vecchiarelli Silvia, Venturi Michela, Verlicchi Lea, Zucchini Giorgia | 2015-01-01 | - | Bologna University Press | 2.01 Capitolo / saggio in libro | - |
MicroRNA profiling of primary pulmonary enteric adenocarcinoma shows similarity with lung cancer and pancreatic cancer | Ingrid Garajová; Niccola Funel; Michelangelo Fiorentino; [..]; Elisa Giovannetti | 2015-01-01 | - | - | 4.03 Poster | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile